00000000|MMI|227.02|Mongolia|C0026410|[geoa]|["MG"-tx-14-"mg"-noun-0,"MG"-tx-8-"MG"-noun-0,"MG"-tx-8-"mg"-noun-0,"MG"-tx-7-"MG"-noun-0,"MG"-tx-6-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|4139/2;[2693/2],[2863/2],[2925/2];3081/2;2420/2;2262/2;[949/2],[1034/2],[1570/2],[1748/2],[1802/2],[1851/2];[482/2],[733/2]|Z01.252.474.651
00000000|MMI|212.02|Portugal|C0032729|[geoa]|["PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[2696/2],[2829/2],[2866/2],[2953/2];2423/2;[2078/2],[2207/2],[2265/2];[952/2],[1037/2],[1573/2],[1636/2],[1702/2],[1805/2],[1854/2];485/2|Z01.542.727
00000000|MMI|114.23|Oral|C0442027|[spco]|["Oral"-tx-8-"ORAL"-adj-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2534/4;[2696/2],[2829/2],[2866/2],[2953/2];2423/2;[2078/2],[2207/2],[2265/2];[952/2],[1037/2],[1573/2],[1636/2],[1702/2],[1805/2],[1854/2];485/2|
00000000|MMI|76.89|Ivory Coast|C0022326|[geoa]|["IV"-tx-28-"IV"-noun-0,"IV"-tx-27-"IV"-noun-0,"IV"-tx-26-"IV"-noun-0,"IV"-tx-17-"iv"-noun-0,"IV"-tx-4-"IV"-noun-0,"IV"-tx-2-"IV"-noun-0]|TX|4710/2;4679/2;4586/2;4210/2;1751/2;736/2|Z01.058.290.190.272
00000000|MMI|76.36|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-verb-0,"Discharge"-tx-10-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5022/9;4870/9;3372/9;159/9;241/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|70.36|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-7-"grapefruit"-noun-0,"grapefruit"-tx-6-"grapefruit"-noun-0,"grapefruit"-tx-4-"grapefruit"-noun-0]|TX|2469/10;2345/10;1901/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|61.20|Daily|C0332173|[tmco]|["QD"-tx-29-"qd"-noun-0,"/day"-tx-8-"day"-noun-0,"QD"-tx-8-"QD"-noun-0,"QD"-tx-7-"QD"-noun-0,"QD"-tx-6-"QD"-noun-0,"QD"-tx-4-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|[4750/2],[4764/2],[4778/2];3092/3;[2869/2],[2967/2],[3025/2],[3084/2],[3174/2];2426/2;[2081/2],[2268/2];1705/2;[550/2],[666/2]|
00000000|MMI|60.85|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-14-"mg"-noun-0,"Mg++"-tx-8-"MG"-noun-0,"Mg++"-tx-8-"mg"-noun-0,"Mg++"-tx-7-"MG"-noun-0,"Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|4139/2;[2693/2],[2863/2],[2925/2];3081/2;2420/2;2262/2;[949/2],[1034/2],[1570/2],[1748/2],[1802/2],[1851/2];[482/2],[733/2]|
00000000|MMI|60.85|Milligram percent|C1960952|[qnco]|["mg %"-tx-14-"mg"-noun-0,"mg %"-tx-8-"MG"-noun-0,"mg %"-tx-8-"mg"-noun-0,"mg %"-tx-7-"MG"-noun-0,"mg %"-tx-6-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|4139/2;[2693/2],[2863/2],[2925/2];3081/2;2420/2;2262/2;[949/2],[1034/2],[1570/2],[1748/2],[1802/2],[1851/2];[482/2],[733/2]|
00000000|MMI|60.85|mg/dL|C0439269|[qnco]|["mg%"-tx-14-"mg"-noun-0,"mg%"-tx-8-"MG"-noun-0,"mg%"-tx-8-"mg"-noun-0,"mg%"-tx-7-"MG"-noun-0,"mg%"-tx-6-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|4139/2;[2693/2],[2863/2],[2925/2];3081/2;2420/2;2262/2;[949/2],[1034/2],[1570/2],[1748/2],[1802/2],[1851/2];[482/2],[733/2]|
00000000|MMI|60.10|Tobramycin|C0040341|[antb,orch]|["TOBRAMYCIN"-tx-27-"tobramycin"-noun-0,"TOBRAMYCIN"-tx-26-"tobramycin"-noun-0,"TOBRAMYCIN"-tx-17-"tobramycin"-noun-0,"TOBRAMYCIN"-tx-11-"tobramycin"-noun-0]|TX|4682/10;4589/10;4197/10;3936/10|D09.408.051.476.600.800
00000000|MMI|59.87|Prednisone|C0032952|[horm,orch,phsu]|["PREDNISONE"-tx-29-"Prednisone"-noun-0,"PREDNISONE"-tx-15-"prednisone"-noun-0,"PRED"-tx-14-"Pred"-noun-0,"PREDNISONE"-tx-8-"PREDNISONE"-noun-0]|TX|4727/10;4166/10;4128/4;2936/10|D04.808.745.432.719.702
00000000|MMI|44.47|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-19-"ASA"-noun-0,"Acetylsalicylic Acid"-tx-2-"ACETYLSALICYLIC ACID"-noun-0]|TX|4265/3;505/20|D02.455.426.559.389.657.410.595.176
00000000|MMI|44.10|Ceftazidime|C0007559|[antb,orch]|["CEFTAZIDIME"-tx-11-"ceftazidime"-noun-0,"CEFTAZIDIME"-tx-2-"CEFTAZIDIME"-noun-0]|TX|3920/11;713/11|D02.065.589.099.249.210.150;D02.886.665.074.210.150;D04.075.080.875.099.221.249.210.150
00000000|MMI|39.23|Pneumonia|C0032285|[dsyn]|["PNEUMONIA"-tx-10-"pneumonia"-noun-0,"PNEUMONIA"-tx-1-"pneumonia"-noun-0]|TX|[3352/9],[3441/9],[3652/9],[3664/9];65/9|C08.381.677;C08.730.610
00000000|MMI|37.70|Lesotho|C0023376|[geoa]|["LT"-tx-6-"lt"-noun-0]|TX|[2098/2],[2285/2],[2298/2]|Z01.058.290.175.400
00000000|MMI|37.57|Dominican Republic|C0013014|[geoa]|["DR"-tx-30-"Dr"-noun-0,"DR"-tx-29-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0]|TX|4919/2;4803/2;3272/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|37.38|Albuterol|C0001927|[orch,phsu]|["ALBUTEROL"-tx-8-"ALBUTEROL"-noun-0,"ALBUTEROL"-tx-2-"ALBUTEROL"-noun-0]|TX|[2580/9],[2881/9];553/9|D02.033.100.291.057;D02.092.063.291.057;D02.092.471.683.061
00000000|MMI|37.27|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-7-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-4-"Food/Drug Interaction"-noun-0]|TX|2429/21;2305/21;1861/21|G07.690.773.968.511
00000000|MMI|37.08|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-8-"INH"-noun-0]|TX|[2611/3],[2762/3],[2928/3]|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|36.97|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-10-"DIAGNOSIS"-noun-0]|TX|[3341/9],[3457/9]|x.x.x.x.x.x.x
00000000|MMI|34.76|Pravachol|C0700763|[orch,phsu]|["Pravachol"-tx-19-"pravachol"-noun-0,"Pravachol"-tx-4-"PRAVACHOL"-noun-0]|TX|4253/9;1822/9|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|34.39|Syncope|C0039070|[sosy]|["FAINT"-tx-12-"faint"-noun-0]|TX|[3997/5],[4031/5]|C10.597.606.358.800.600;C23.888.592.604.359.800.600
00000000|MMI|34.26|Give - dosing instruction imperative|C1947971|[ftcn]|["Give"-tx-8-"Give"-verb-0,"Give"-tx-4-"give"-verb-0]|TX|[2956/4],[3014/4],[3073/4];[1262/4],[1314/4],[1366/4],[1418/4],[1470/4]|
00000000|MMI|34.26|Then|C1883708|[tmco]|["Then"-tx-8-"then"-adv-0,"Then"-tx-4-"then"-adv-0]|TX|[3001/4],[3060/4],[3118/4];[1257/4],[1309/4],[1361/4],[1413/4],[1465/4]|
00000000|MMI|32.13|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-10-"gerd"-noun-0,"Gastrooesophageal reflux disease"-tx-10-"gastroesophageal reflux disease"-noun-0]|TX|3564/4;3571/31|C06.405.117.119.500.484
00000000|MMI|30.63|Chronic Obstructive Airway Disease|C0024117|[dsyn]|["-- COPD"-tx-10-"COPD"-noun-0,"-- COPD"-tx-10-"copd"-noun-0,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"-tx-10-"chronic obstructive pulmonary disease"-noun-0]|TX|3820/4;3605/4;3612/37|C08.381.495.389
00000000|MMI|30.45|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-8-"TAB"-noun-0,"TAB"-tx-6-"TAB"-noun-0,"TABLET"-tx-6-"TABLET"-noun-0]|TX|2825/3;[1984/3],[2203/3];1973/6|D26.255.830
00000000|MMI|30.28|Physicians|C0031831|[prog]|["DR"-tx-30-"Dr"-noun-0,"DR"-tx-29-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0]|TX|4919/2;4803/2;3272/2|M01.526.485.810;N02.360.810
00000000|MMI|29.72|Morphine|C0026549|[orch,phsu]|["MORPHINE"-tx-24-"morphine"-noun-0,"MORPHINE"-tx-4-"MORPHINE"-noun-0]|TX|4511/8;1770/8|D03.132.577.249.562.571;D03.549.686.607.587;D03.605.497.607.587;D04.615.723.795.576.571
00000000|MMI|29.47|Ativan|C0699194|[orch,phsu]|["Ativan"-tx-26-"ativan"-noun-0,"Ativan"-tx-4-"ATIVAN"-noun-0]|TX|4533/6;1545/6|D03.438.079.080.070.450
00000000|MMI|27.29|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-30-"tylenol"-noun-0,"Tylenol"-tx-2-"TYLENOL"-noun-0]|TX|4856/7;452/7|D02.065.199.092.040
00000000|MMI|26.10|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-12-"BS"-noun-0,"BS"-tx-12-"bs"-noun-0,"BS"-tx-4-"BS"-noun-0]|TX|4003/2;4074/2;[1235/2],[1293/2],[1345/2],[1397/2],[1449/2],[1522/2]|
00000000|MMI|26.10|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-12-"BS"-noun-0,"BS"-tx-12-"bs"-noun-0,"BS"-tx-4-"BS"-noun-0]|TX|4003/2;4074/2;[1235/2],[1293/2],[1345/2],[1397/2],[1449/2],[1522/2]|
00000000|MMI|26.10|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-12-"BS"-noun-0,"BS"-tx-12-"bs"-noun-0,"BS"-tx-4-"BS"-noun-0]|TX|4003/2;4074/2;[1235/2],[1293/2],[1345/2],[1397/2],[1449/2],[1522/2]|
00000000|MMI|24.66|Fluorides|C0016327|[inch,phsu]|["F-"-tx-30-"F"-noun-0,"F-"-tx-6-"F"-noun-0]|TX|4910/1;2218/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|24.65|Pain|C0030193|[sosy]|["PAIN"-tx-23-"pain"-noun-0,"PAIN"-tx-4-"Pain"-noun-0]|TX|4455/4;1817/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|23.24|Humibid|C0729017|[orch,phsu]|["Humibid"-tx-5-"HUMIBID"-noun-0]|TX|1943/7|D02.355.601.536.400;D02.355.726.453.400;D02.455.426.559.389.657.166.453.400;D02.455.426.559.389.657.654.453.400
00000000|MMI|21.94|Guaifenesin|C0018305|[orch,phsu]|["Guaiphenesin"-tx-6-"GUAIFENESIN"-noun-0]|TX|1958/11|D02.355.601.536.400;D02.355.726.453.400;D02.455.426.559.389.657.166.453.400;D02.455.426.559.389.657.654.453.400
00000000|MMI|21.94|Obesity|C0028754|[dsyn]|["OBESE"-tx-12-"obese"-adj-0]|TX|3960/5|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|20.83|Hippocampus Proper|C3887642|[bpoc]|["CA"-tx-8-"CA"-adj-0]|TX|2815/2|A08.186.211.464.405;A08.186.211.730.885.287.500.345
00000000|MMI|20.36|Approximate|C0332232|[qlco]|["Approximate"-tx-8-"approximate"-adj-0,"Approximate"-tx-6-"approximate"-adj-0,"Approximate"-tx-4-"approximate"-adj-0,"Approximate"-tx-2-"approximate"-adj-0]|TX|2646/11;[2022/11],[2132/11];986/11;696/11|
00000000|MMI|20.36|Requirement|C1514873|[ftcn]|["Required"-tx-8-"Required"-verb-0,"Required"-tx-6-"Required"-verb-0,"Required"-tx-4-"Required"-verb-0,"Required"-tx-2-"Required"-verb-0]|TX|2635/8;[2011/8],[2121/8];975/8;685/8|
00000000|MMI|20.28|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-30-"PLAN"-noun-0,"PLAN"-tx-12-"Plan"-verb-0]|TX|4904/4;4077/4|C10.228.140.744
00000000|MMI|20.09|Wheezing|C0043144|[sosy]|["Wheezes"-tx-12-"wheezes"-noun-0,"WHEEZING"-tx-2-"Wheezing"-verb-0]|TX|4018/7;614/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|20.05|Facial Hemiatrophy|C0015458|[dsyn]|["HFA"-tx-8-"HFA"-noun-0]|TX|[2574/3],[2598/3]|C07.465.284;C07.465.299.375;C10.292.319.375
00000000|MMI|19.85|Oxygen|C0030054|[elii,phsu]|["O2"-tx-13-"O2"-noun-0,"O2"-tx-10-"O2"-noun-0]|TX|4097/2;3833/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|19.77|PO-2|C0297199|[orch]|["PO-2"-tx-6-"2 PO"-noun-0,"PO-2"-tx-2-"PO 2"-noun-0]|TX|1982/1,1988/2;547/2,573/1|x.x.x.x
00000000|MMI|19.55|Ipratropium|C0027235|[orch,phsu]|["IPRATROPIUM"-tx-8-"IPRATROPIUM"-noun-0]|TX|2895/11|D02.145.074.722.229.400;D03.132.760.180.572.400;D03.132.889.180.648.400;D03.605.869.229.400;D04.075.080.875.099.722.229.400
00000000|MMI|19.52|Regular Insulin, Human|C0795635|[aapp,horm,phsu]|["INSULIN HUMAN"-tx-4-"INSULIN HUMAN"-noun-0]|TX|1069/7,1085/5|D06.472.699.587.200.500.625.500;D12.644.548.586.200.500.625.500
00000000|MMI|18.42|Cephalosporins|C3536856|[antb,orch]|["CEPHALOSPORINS"-tx-4-"CEPHALOSPORINS"-noun-0]|TX|854/14|D02.065.589.099.249;D02.886.665.074;D04.075.080.875.099.221.249
00000000|MMI|18.42|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-19-"ASA"-noun-0]|TX|4265/3|D08.811.277.352.827.070.250
00000000|MMI|18.42|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-10-"Penicillins"-noun-0]|TX|3311/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|18.42|Pravastatin|C0085542|[orch,phsu]|["PRAVASTATIN"-tx-4-"PRAVASTATIN"-noun-0]|TX|1834/11|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|18.42|Surgical aspects|C0038895|[ftcn]|["operations"-tx-10-"OPERATIONS"-noun-0]|TX|3676/10|x.x.x.x.x.x.x
00000000|MMI|18.42|Trimethoprim-Sulfamethoxazole Combination|C0041044|[phsu]|["Trimethoprim-sulphamethoxazole"-tx-6-"TRIMETHOPRIM SULFAMETHOXAZOLE"-noun-0]|TX|2162/12,2176/16|D02.065.884.725.867.500;D02.092.146.807.867.500;D02.886.590.700.725.867.500;D03.383.742.906.500;D26.310.875
00000000|MMI|18.42|Walking (activity)|C0080331|[dora]|["Walking"-tx-8-"Walking"-noun-0]|TX|3223/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|17.22|Advair Diskus|C0939246|[orch,phsu]|["Advair Diskus"-tx-8-"ADVAIR DISKUS"-noun-0]|TX|2703/13|D02.033.100.291.057.750.500;D02.092.063.291.057.750.500;D02.092.471.683.061.750.500;D04.808.054.079.129.114.500;D26.310.438
00000000|MMI|17.08|Chimerin 1|C0067895|[aapp,bacs]|["NC"-tx-13-"NC"-noun-0]|TX|4103/2|D12.644.360.325.150.100.200;D12.776.476.325.150.100.200;D12.776.641.124.200
00000000|MMI|16.63|10%|C3842590|[fndg]|["10%"-tx-8-"10"-integer-0,"10%"-tx-4-"10"-integer-0,"10%"-tx-1-"10"-fraction-0]|TX|[2661/2],[2690/2],[3089/2];[946/2],[1475/2];101/2|
00000000|MMI|16.35|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-10-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0,"Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|3302/7;824/7;837/11|C20.543
00000000|MMI|16.01|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-4-"DOCUSATE SODIUM"-noun-0]|TX|1012/15|D02.241.081.337.759.249
00000000|MMI|16.01|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-8-"ESOMEPRAZOLE"-noun-0]|TX|2845/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|16.01|Lorazepam|C0024002|[orch,phsu]|["LORAZEPAM"-tx-4-"LORAZEPAM"-noun-0]|TX|1554/9|D03.438.079.080.070.450
00000000|MMI|16.01|Magnesium Hydroxide|C0024476|[inch,phsu]|["MAGNESIUM HYDROXIDE"-tx-4-"MAGNESIUM HYDROXIDE"-noun-0]|TX|1665/19|D01.045.250.575;D01.248.497.158.459.388;D01.524.485
00000000|MMI|16.01|Pulmicort|C0678162|[orch,phsu]|["Pulmicort"-tx-8-"PULMICORT"-noun-0]|TX|2511/9|D04.808.745.745.654.105
00000000|MMI|16.01|Shellfish|C1304606|[euka]|["SHELLFISH"-tx-10-"Shellfish"-noun-0]|TX|3325/9|G07.203.300.600.875.700;J02.500.600.875.700
00000000|MMI|16.01|Weaning|C0043084|[fndg]|["wean"-tx-24-"wean"-verb-0]|TX|4499/4|G07.203.650.220.500.750;G07.203.650.593.762;G07.700.620.762
00000000|MMI|15.99|Disease|C0012634|[dsyn]|["condition"-tx-30-"CONDITION"-noun-0,"condition"-tx-10-"Conditions"-noun-0]|TX|4880/9;3467/10|C23.550.288
00000000|MMI|15.62|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-7-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0]|TX|2451/11;2327/11;1883/11|I02.903
00000000|MMI|15.54|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-10-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3302/7;824/7|H02.403.044
00000000|MMI|15.37|Nebulizers|C0027524|[medd]|["Nebuliser"-tx-26-"nebulizer"-noun-0,"Nebuliser"-tx-8-"NEBULIZER"-noun-0,"Nebuliser"-tx-2-"NEBULIZER"-noun-0]|TX|4630/9;2907/9;563/9|E07.605
00000000|MMI|15.21|Anxiety|C0003467|[mobd]|["-- Anxiety"-tx-26-"Anxiety"-noun-0,"-- Anxiety"-tx-4-"Anxiety"-noun-0]|TX|4524/7;1586/7|F01.470.132
00000000|MMI|14.86|Colace|C0282139|[orch,phsu]|["Colace"-tx-4-"COLACE"-noun-0]|TX|1003/6|D02.241.081.337.759.249
00000000|MMI|14.80|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-8-"NEXIUM"-noun-0]|TX|2836/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|14.80|MS Contin|C0700786|[orch,phsu]|["Contin, MS"-tx-4-"MS CONTIN"-noun-0]|TX|1758/9|D03.132.577.249.562.571;D03.549.686.607.587;D03.605.497.607.587;D04.615.723.795.576.571
00000000|MMI|14.75|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|319/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|14.71|Budesonide|C0054201|[orch,phsu]|["BUDESONIDE"-tx-8-"BUDESONIDE"-noun-0]|TX|2523/10|D04.808.745.745.654.105
00000000|MMI|14.71|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-12-"NAD"-noun-0]|TX|3968/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|14.69|Pseudomonas|C0033808|[bact]|["PSEUDOMONAS"-tx-10-"pseudomonas"-noun-0]|TX|3884/11|B03.440.400.425.625.625;B03.660.250.580.590
00000000|MMI|14.69|Tobramycin Sulfate|C0027519|[antb,orch]|["Tobramycin sulphate"-tx-4-"TOBRAMYCIN SULFATE"-noun-0]|TX|1725/18|D09.408.051.476.600.800
00000000|MMI|14.67|North Carolina|C0028407|[geoa]|["NC"-tx-13-"NC"-noun-0]|TX|4103/2|Z01.107.567.875.075.475;Z01.107.567.875.750.530
00000000|MMI|14.27|Unit|C0439148|[qnco]|["UNITS"-tx-4-"units"-noun-0]|TX|[1269/5],[1321/5],[1373/5],[1425/5],[1478/5]|
00000000|MMI|14.27|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-4-"units"-noun-0]|TX|[1269/5],[1321/5],[1373/5],[1425/5],[1478/5]|
00000000|MMI|14.27|Unit of Measure|C1519795|[qnco]|["Units"-tx-4-"units"-noun-0]|TX|[1269/5],[1321/5],[1373/5],[1425/5],[1478/5]|
00000000|MMI|14.00|Dose number|C1115464|[qnco]|["Dose number"-tx-8-"Number Doses"-noun-0,"Dose number"-tx-6-"Number Doses"-noun-0,"Dose number"-tx-4-"Number Doses"-noun-0,"Dose number"-tx-2-"Number Doses"-noun-0]|TX|2619/6,2629/5;[1995/6,2005/5],[2105/6,2115/5];959/6,969/5;669/6,679/5|
00000000|MMI|14.00|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-8-"Number Doses"-noun-0,"Dose number"-tx-6-"Number Doses"-noun-0,"Dose number"-tx-4-"Number Doses"-noun-0,"Dose number"-tx-2-"Number Doses"-noun-0]|TX|2619/6,2629/5;[1995/6,2005/5],[2105/6,2115/5];959/6,969/5;669/6,679/5|
00000000|MMI|13.77|1+|C3816745|[fndg]|["1+"-tx-12-"1"-integer-0,"1+"-tx-8-"1"-integer-0,"1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4083/1;[2549/1],[2755/1];2201/1;655/1|
00000000|MMI|13.77|1+ Score|C2827734|[qnco]|["1+"-tx-12-"1"-integer-0,"1+"-tx-8-"1"-integer-0,"1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4083/1;[2549/1],[2755/1];2201/1;655/1|
00000000|MMI|13.77|1+ Score, WHO|C2981698|[clas]|["1+"-tx-12-"1"-integer-0,"1+"-tx-8-"1"-integer-0,"1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4083/1;[2549/1],[2755/1];2201/1;655/1|
00000000|MMI|13.75|Tapering - action|C0441640|[hlca]|["Taper"-tx-29-"taper"-noun-0,"Taper"-tx-15-"taper"-noun-0,"tapered"-tx-14-"Tapered"-adj-0,"Taper"-tx-8-"Taper"-noun-0,"Taper"-tx-8-"taper"-noun-0]|TX|4738/5;4177/5;4120/7;2947/5;3137/5|
00000000|MMI|13.60|Acetaminophen|C0000970|[orch,phsu]|["ACETAMINOPHEN"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|462/13|D02.065.199.092.040
00000000|MMI|12.51|Back Pain|C0004604|[sosy]|["BACKPAIN"-tx-22-"back pain"-noun-0]|TX|4349/9|C10.597.617.140;C23.888.592.612.107
00000000|MMI|12.45|Prevacid|C0286036|[orch,phsu]|["Prevacid"-tx-20-"prevacid"-noun-0]|TX|4297/8|D02.886.640.074.249;D03.383.725.024.249;D03.438.103.034.249
00000000|MMI|12.32|Fat-Restricted Diet|C0242970|[topp]|["low fat"-tx-8-"Low fat"-noun-0]|TX|3191/3,3209/3|E02.642.249.260;G07.203.650.240.260
00000000|MMI|12.28|Proventil|C0699770|[orch,phsu]|["Proventil"-tx-8-"PROVENTIL"-noun-0]|TX|2564/9|D02.033.100.291.057;D02.092.063.291.057;D02.092.471.683.061
00000000|MMI|12.28|Headache|C0018681|[sosy]|["HEADACHE"-tx-2-"headache"-noun-0]|TX|496/8|C10.597.617.470;C23.888.592.612.441
00000000|MMI|12.28|Tonga (Geographic Area)|C0040407|[geoa]|["TON"-tx-1-"Ton"-noun-0]|TX|224/3|Z01.639.760.815.890
00000000|MMI|12.28|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-4-"SC"-noun-0]|TX|1062/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|12.26|New Caledonia|C0027964|[geoa]|["NC"-tx-13-"NC"-noun-0]|TX|4103/2|Z01.639.760.590.620
00000000|MMI|12.25|Lidocaine|C0023660|[orch,phsu]|["LIDOCAINE"-tx-23-"lidocaine"-noun-0]|TX|4403/9|D02.065.199.092.500
00000000|MMI|11.99|Continuous|C0549178|[idcn]|["Continue"-tx-28-"continue"-verb-0,"Continue"-tx-26-"continue"-verb-0,"Continue"-tx-8-"continue"-verb-0]|TX|4701/8;4577/8;3145/8|
00000000|MMI|11.99|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-32-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|4981/3;810/3;396/3|
00000000|MMI|11.99|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-6-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-4-"grapefruit"-noun-0]|TX|2469/10;2345/10;1901/10|
00000000|MMI|11.99|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-6-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-4-"grapefruit"-noun-0]|TX|2469/10;2345/10;1901/10|
00000000|MMI|11.99|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-7-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-6-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-4-"grapefruit"-noun-0]|TX|2469/10;2345/10;1901/10|
00000000|MMI|11.43|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-verb-0,"Discharge"-tx-10-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5022/9;4870/9;3372/9;159/9|
00000000|MMI|11.43|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-33-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-verb-0,"Discharge"-tx-10-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5022/9;4870/9;3372/9;159/9|
00000000|MMI|11.33|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-31-"M"-noun-0,"M NOS"-tx-9-"m"-noun-0,"M NOS"-tx-6-"M"-noun-0,"M NOS"-tx-2-"M"-noun-0]|TX|4976/1;3288/1;2210/1;805/1|
00000000|MMI|11.33|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-31-"M"-noun-0,"M+"-tx-9-"m"-noun-0,"M+"-tx-6-"M"-noun-0,"M+"-tx-2-"M"-noun-0]|TX|4976/1;3288/1;2210/1;805/1|
00000000|MMI|11.24|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-7-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0,"instructions"-tx-4-"Instructions"-noun-0]|TX|2451/11;2327/11;1883/11;1131/12|
00000000|MMI|11.24|Instructions|C1442085|[idcn]|["instruction"-tx-7-"Instruction"-noun-0,"instruction"-tx-6-"Instruction"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0,"instruction"-tx-4-"Instruction"-noun-0]|TX|2451/11;2327/11;1131/12;1883/11|
00000000|MMI|11.19|Cardizem|C0700940|[orch,phsu]|["Cardizem"-tx-19-"cardizem"-noun-0]|TX|4242/8|D03.438.079.150
00000000|MMI|11.19|Diltiazem|C0012373|[orch,phsu]|["DILTIAZEM"-tx-6-"DILTIAZEM"-noun-0]|TX|2229/9|D03.438.079.150
00000000|MMI|11.19|ECHO protocol|C0058928|[topp]|["ECHO"-tx-19-"ECHO"-noun-0]|TX|4271/4|x.x.x.x
00000000|MMI|11.19|Endometriosis|C0014175|[dsyn]|["Endo"-tx-21-"Endo"-adj-0]|TX|4309/4|C13.351.500.163
00000000|MMI|11.19|montelukast|C0298130|[orch,phsu]|["MONTELUKAST"-tx-8-"MONTELUKAST"-noun-0]|TX|2676/11|x.x.x.x
00000000|MMI|11.19|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-12-"PE"-noun-0]|TX|3948/2|x.x.x.x
00000000|MMI|11.19|salmon calcitonin|C0073994|[aapp,horm,phsu]|["CALCITONIN SALMON"-tx-2-"CALCITONIN-SALMON"-noun-0]|TX|635/17|x.x.x.x
00000000|MMI|10.89|4+ Answer to question|C3838679|[fndg]|["4+"-tx-6-"4"-integer-0,"4+"-tx-4-"4"-integer-0,"4+"-tx-2-"4"-integer-0]|TX|[2037/1],[2147/1];1319/1;711/1|
00000000|MMI|10.84|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-8-"TAB"-noun-0,"TABLET"-tx-6-"TABLET"-noun-0,"Tab"-tx-6-"TAB"-noun-0]|TX|2825/3;1973/6;[1984/3],[2203/3]|
00000000|MMI|10.71|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-10-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3302/7;824/7|C20.543
00000000|MMI|10.38|Anxiety Disorders|C0003469|[mobd]|["Anxiety"-tx-26-"Anxiety"-noun-0,"Anxiety"-tx-4-"Anxiety"-noun-0]|TX|4524/7;1586/7|F03.080
00000000|MMI|10.27|Inhaler|C0021461|[medd]|["INHALER"-tx-8-"INHALER"-noun-0]|TX|[2539/7],[2590/7]|E07.605
00000000|MMI|10.04|Abdominal Cavity|C0230168|[blor]|["Abdomen"-tx-12-"Abdomen"-noun-0]|TX|4045/7|A01.923.047.025
00000000|MMI|10.04|Chest|C0817096|[blor]|["CHEST"-tx-12-"Chest"-noun-0]|TX|3990/5|A01.923.761;A02.835.232.904
00000000|MMI|10.04|Tiazac|C0723743|[orch,phsu]|["Tiazac"-tx-6-"TIAZAC"-noun-0]|TX|2220/6|D03.438.079.150
00000000|MMI|9.98|Heparin|C0019134|[bacs,orch,phsu]|["HEPARIN"-tx-4-"HEPARIN"-noun-0]|TX|1044/7|D09.698.373.400
00000000|MMI|9.97|Coughing|C0010200|[sosy]|["COUGHING"-tx-22-"coughing"-noun-0]|TX|4387/8|C08.618.248;C23.888.852.293
00000000|MMI|9.96|Rabbi|C0684010|[prog]|["R."-tx-10-"R"-noun-0]|TX|3747/1|M01.526.799.500
00000000|MMI|9.95|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-2-"Shortness of Breath"-noun-0]|TX|592/19|C08.618.326;C23.888.852.371
00000000|MMI|9.94|prednylidene|C0044955|[orch,phsu]|["Pred"-tx-14-"Pred"-noun-0]|TX|4128/4|x.x.x.x
00000000|MMI|9.93|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|319/3|E04.157.310;E04.950.300.299
00000000|MMI|9.91|Calcium|C0006675|[bacs,elii,phsu]|["CALCIUM"-tx-8-"CALCIUM"-noun-0]|TX|2785/7|D01.268.552.100;D01.552.539.288;D23.119.100;x.x.x.x
00000000|MMI|9.89|Rehabilitation therapy|C0034991|[topp]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|414/14|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|9.88|Honduras|C0019905|[geoa]|["HO"-tx-4-"HO"-noun-0]|TX|1508/2|Z01.107.169.534
00000000|MMI|9.87|Dyspepsia|C0013395|[sosy]|["INDIGESTION"-tx-4-"Indigestion"-noun-0]|TX|1647/11|C23.888.821.236
00000000|MMI|9.87|Panama|C0030266|[geoa]|["PM"-tx-4-"pm"-adj-0]|TX|1218/2|Z01.107.169.772
00000000|MMI|9.86|Constipation|C0009806|[sosy]|["CONSTIPATION"-tx-4-"Constipation"-noun-0]|TX|1712/12|C23.888.821.150
00000000|MMI|9.86|Pain management|C0002766|[topp]|["Management, Pain"-tx-30-"Pain management"-noun-0]|TX|4833/15|E02.745;N04.590.607.500
00000000|MMI|9.85|dioctadecylamidospermine|C0640640|[orch]|["1-DOS"-tx-2-"1 Doses"-noun-0]|TX|655/1,679/5|x.x.x.x
00000000|MMI|9.85|Diet|C0012155|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|3177/4|G07.203.650.240
00000000|MMI|9.84|Shoulder|C0037004|[blor]|["SHOULDER"-tx-23-"shoulder"-noun-0]|TX|4422/8|A01.378.800.750
00000000|MMI|8.95|Order (action)|C1705178|[acty]|["Order"-tx-33-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.95|Order (arrangement)|C1705176|[qlco]|["Order"-tx-33-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.95|Order (document)|C1705175|[inpr]|["Order"-tx-33-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.95|Order (taxonomic)|C1705177|[clas]|["Order"-tx-33-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.95|Permutation|C1882348|[qlco]|["Order"-tx-33-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.95|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-33-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5032/6;323/5;169/6|
00000000|MMI|8.80|Override|C1547671|[acty]|["Override"-tx-4-"override"-verb-0,"Override"-tx-2-"Override"-verb-0,"Override"-tx-2-"overridden"-noun-0]|TX|880/8;761/8;749/10|
00000000|MMI|8.78|Child|C0008059|[aggp]|["Children"-tx-2-"CHILDREN"-noun-0]|TX|528/8|M01.060.406
00000000|MMI|8.78|Complication Aspects|C1171258|[patf]|["complications"-tx-10-"Complications"-noun-0]|TX|3493/13|x.x.x
00000000|MMI|8.78|Drawings (art)|C0013113|[inpr]|["Draw"-tx-4-"draw"-verb-0]|TX|1160/4|V01.185.625;V02.700.300
00000000|MMI|8.78|Hypertensive disease|C0020538|[dsyn]|["HYPERTENSION"-tx-10-"hypertension"-noun-0]|TX|3549/12|C14.907.489
00000000|MMI|8.78|Laboratory|C0022877|[mnob,orgt]|["Lab"-tx-4-"lab"-noun-0]|TX|1156/3|N02.278.487
00000000|MMI|8.78|Methods aspects|C0025664|[inpr]|["procedures"-tx-10-"PROCEDURES"-noun-0]|TX|3691/10|x.x.x
00000000|MMI|8.78|utilization qualifier|C0042153|[ftcn]|["use"-tx-4-"use"-verb-0]|TX|1149/3|x.x.x
00000000|MMI|8.57|milligram/day|C0439422|[qnco]|["mg day"-tx-8-"mg day"-noun-0]|TX|[2964/2,2974/3],[3022/2,3032/3],[3081/2,3092/3]|
00000000|MMI|8.51|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-6-"lt"-noun-0]|TX|[2098/2],[2285/2],[2298/2]|
00000000|MMI|8.51|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-6-"lt"-noun-0]|TX|[2098/2],[2285/2],[2298/2]|
00000000|MMI|8.39|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-30-"Dr"-noun-0,"DR"-tx-29-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0]|TX|4919/2;4803/2;3272/2|
00000000|MMI|8.39|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-30-"Dr"-noun-0,"DR"-tx-29-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0]|TX|4919/2;4803/2;3272/2|
00000000|MMI|8.39|Doctor - Title|C2348314|[cnce]|["Dr."-tx-30-"Dr"-noun-0,"Dr."-tx-29-"Dr"-noun-0,"Dr."-tx-8-"Dr"-noun-0]|TX|4919/2;4803/2;3272/2|
00000000|MMI|8.33|100%|C3817553|[qnco]|["100%"-tx-6-"100"-integer-0,"100%"-tx-4-"100"-integer-0]|TX|[2101/3],[2288/3];1030/3|
00000000|MMI|8.19|+2|C0740116|[qnco]|["+2"-tx-16-"2"-integer-0,"+2"-tx-8-"2"-integer-0]|TX|4184/1;[2604/1],[2823/1]|
00000000|MMI|8.19|2+|C3833492|[fndg]|["2+"-tx-16-"2"-integer-0,"2+"-tx-8-"2"-integer-0]|TX|4184/1;[2604/1],[2823/1]|
00000000|MMI|8.19|2+ Score|C2827735|[qnco]|["2+"-tx-16-"2"-integer-0,"2+"-tx-8-"2"-integer-0]|TX|4184/1;[2604/1],[2823/1]|
00000000|MMI|8.19|2+ Score, WHO|C2981700|[clas]|["2+"-tx-16-"2"-integer-0,"2+"-tx-8-"2"-integer-0]|TX|4184/1;[2604/1],[2823/1]|
00000000|MMI|8.07|Nebulizer Device Component|C1709156|[mnob]|["Nebulizer"-tx-26-"nebulizer"-noun-0,"Nebulizer"-tx-8-"NEBULIZER"-noun-0,"Nebulizer"-tx-2-"NEBULIZER"-noun-0]|TX|4630/9;2907/9;563/9|
00000000|MMI|8.01|0%|C3842591|[fndg]|["0%"-tx-26-"0"-integer-0,"0%"-tx-8-"0"-fraction-0,"0%"-tx-4-"0"-integer-0]|TX|4540/1;2921/1;1267/1|
00000000|MMI|7.97|Picofarad (unit of measure)|C1882376|[qnco]|["Puff"-tx-8-"PUFF"-noun-0]|TX|[2551/4],[2606/4],[2757/4]|
00000000|MMI|7.97|Puff unit dose|C1533107|[qnco]|["PUFF"-tx-8-"PUFF"-noun-0]|TX|[2551/4],[2606/4],[2757/4]|
00000000|MMI|7.96|30%|C3842588|[fndg]|["30%"-tx-14-"30"-integer-0,"30%"-tx-8-"30"-integer-0,"30%"-tx-4-"30"-integer-0]|TX|4136/2;2961/2;1687/2|
00000000|MMI|7.95|3 Days|C1442459|[tmco]|["3D"-tx-29-"3d"-adj-0]|TX|[4755/2],[4769/2]|
00000000|MMI|7.95|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-10-"DIAGNOSIS"-noun-0]|TX|[3341/9],[3457/9]|E01
00000000|MMI|7.95|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-10-"DIAGNOSIS"-noun-0]|TX|[3341/9],[3457/9]|
00000000|MMI|7.95|Hold (action)|C1948035|[acty]|["Hold"-tx-6-"HOLD"-verb-0]|TX|[2084/4],[2271/4]|
00000000|MMI|7.95|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-6-"HOLD"-verb-0]|TX|[2084/4],[2271/4]|
00000000|MMI|7.95|PET Scanner 3D Mode|C2986797|[ftcn]|["3D"-tx-29-"3d"-adj-0]|TX|[4755/2],[4769/2]|
00000000|MMI|7.95|Three-dimensional|C0450363|[spco]|["3D"-tx-29-"3d"-adj-0]|TX|[4755/2],[4769/2]|
00000000|MMI|7.95|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-6-"HOLD"-verb-0]|TX|[2084/4],[2271/4]|
00000000|MMI|7.95|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-33-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5032/6;169/6|
00000000|MMI|7.63|Abdomen|C0000726|[blor]|["ABDOMEN"-tx-12-"Abdomen"-noun-0]|TX|4045/7|A01.923.047
00000000|MMI|7.60|Appointments|C0003629|[idcn]|["Appointment"-tx-8-"APPOINTMENT"-noun-0]|TX|3254/11|N04.452.095
00000000|MMI|7.50|Calcium, Dietary|C0006726|[inch]|["Calcium"-tx-8-"CALCIUM"-noun-0]|TX|2785/7|D01.146.315
00000000|MMI|7.48|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|414/14|x.x.x
00000000|MMI|7.44|Diet therapy|C0012159|[hlca]|["Diet"-tx-8-"DIET"-noun-0]|TX|3177/4|E02.642.249
00000000|MMI|6.37|Infection|C3714514|[patf]|["Infections"-tx-10-"Infections"-noun-0]|TX|3480/10|C01.539
00000000|MMI|6.37|Lung|C0024109|[bpoc]|["pulmonary"-tx-13-"pulmonary"-adj-0]|TX|4086/9|A04.411
00000000|MMI|6.37|Patients|C0030705|[podg]|["*^patient"-tx-27-"patient"-noun-0]|TX|4644/7|M01.643
00000000|MMI|6.37|Steroids|C0038317|[orch]|["Steroids"-tx-10-"steroids"-noun-0]|TX|3838/8|D04.808
00000000|MMI|6.31|Condition|C0348080|[qlco]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-10-"Conditions"-noun-0]|TX|4880/9;3467/10|
00000000|MMI|6.31|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-10-"Conditions"-noun-0]|TX|4880/9;3467/10|
00000000|MMI|6.31|Logical Condition|C1705253|[cnce]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-10-"Conditions"-noun-0]|TX|4880/9;3467/10|
00000000|MMI|5.87|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-10-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3302/7;824/7|
00000000|MMI|5.87|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-10-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3302/7;824/7|
00000000|MMI|5.87|Flexeril|C0728797|[orch,phsu]|["Flexeril"-tx-23-"flexeril"-noun-0,"Flexeril"-tx-4-"FLEXERIL"-noun-0]|TX|4475/8;913/8|
00000000|MMI|5.87|Hospital admission|C0184666|[hlca]|["Admission"-tx-10-"Admission"-noun-0,"Admit"-tx-10-"ADMIT"-verb-0]|TX|3429/9;3335/5|
00000000|MMI|5.87|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-10-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0]|TX|3302/7;824/7|
00000000|MMI|5.77|Planned|C1301732|[ftcn]|["Plan"-tx-30-"PLAN"-noun-0,"Plan"-tx-12-"Plan"-verb-0]|TX|4904/4;4077/4|
00000000|MMI|5.77|Treatment Plan|C0599880|[inpr]|["Plan"-tx-30-"PLAN"-noun-0,"Plan"-tx-12-"Plan"-verb-0]|TX|4904/4;4077/4|
00000000|MMI|5.66|Chronic obstructive pulmonary disease of horses|C3714496|[dsyn]|["COPD"-tx-10-"COPD"-noun-0,"COPD"-tx-10-"copd"-noun-0]|TX|3820/4;3605/4|
00000000|MMI|5.62|One Thousand|C1883310|[qnco]|["10^3"-tx-18-"10 3"-fraction-0,"10^3"-tx-1-"3 10"-fraction-0]|TX|4226/2,4235/1;263/1,274/2|
00000000|MMI|5.62|Per Thousand|C4050554|[qnco]|["/10^3"-tx-18-"10 3"-fraction-0,"/10^3"-tx-1-"3 10"-fraction-0]|TX|4226/2,4235/1;263/1,274/2|
00000000|MMI|5.55|sliding scale|C2937251|[topp]|["sliding scale"-tx-4-"Sliding Scale"-noun-0,"sliding scale"-tx-4-"sliding scale"-noun-0]|TX|1091/13;1180/13|
00000000|MMI|5.54|Anxiety Scale (BASC-2)|C4050613|[inpr]|["Anxiety"-tx-26-"Anxiety"-noun-0,"Anxiety"-tx-4-"Anxiety"-noun-0]|TX|4524/7;1586/7|
00000000|MMI|5.54|Every evening|C0585330|[tmco]|["QPM"-tx-21-"qpm"-noun-0,"QPM"-tx-8-"QPM"-noun-0]|TX|4318/3;2699/3|
00000000|MMI|5.54|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-21-"qpm"-noun-0,"qPM"-tx-8-"QPM"-noun-0]|TX|4318/3;2699/3|
00000000|MMI|5.53|Summary (document)|C1706244|[inpr]|["Summary"-tx-31-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|4941/7;348/7|
00000000|MMI|5.53|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-31-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|4941/7;348/7|
00000000|MMI|5.50|Not Applicable|C1272460|[qlco]|["{NA}"-tx-2-"NA"-noun-0,"NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|663/2;299/14|
00000000|MMI|5.50|Package Type Not Applicable|C4049872|[ftcn]|["NA"-tx-2-"NA"-noun-0,"Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|663/2;299/14|
00000000|MMI|5.44|Count of entities|C0449788|[qnco]|["Number"-tx-8-"Number"-noun-0,"Number"-tx-2-"Number"-noun-0]|TX|2619/6;669/6|
00000000|MMI|5.44|Numbers|C0237753|[qnco]|["*Number"-tx-8-"Number"-noun-0,"*Number"-tx-2-"Number"-noun-0]|TX|2619/6;669/6|
00000000|MMI|5.43|Inhaler Dosing Unit|C1881212|[qnco]|["INHALER"-tx-8-"INHALER"-noun-0]|TX|[2539/7],[2590/7]|
00000000|MMI|5.42|55|C0450382|[inpr]|["55"-tx-19-"55"-percentage-0,"55"-tx-6-"55"-integer-0]|TX|4286/2;2302/2|
00000000|MMI|5.40|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-33-"3"-fraction-0,"3+"-tx-8-"3"-fraction-0]|TX|4995/1;2919/1|
00000000|MMI|5.40|3+ Score|C2827736|[qnco]|["3+"-tx-33-"3"-fraction-0,"3+"-tx-8-"3"-fraction-0]|TX|4995/1;2919/1|
00000000|MMI|5.40|3+ Score, WHO|C2981702|[clas]|["3+"-tx-33-"3"-fraction-0,"3+"-tx-8-"3"-fraction-0]|TX|4995/1;2919/1|
00000000|MMI|5.40|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-33-"3"-fraction-0,"<3"-tx-8-"3"-fraction-0]|TX|4995/1;2919/1|
00000000|MMI|5.36|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|319/3;79/3|
00000000|MMI|5.36|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-30-"PUO"-noun-0,"puo"-tx-1-"PUO"-noun-0]|TX|4816/3;12/3|
00000000|MMI|5.31|0/5|C0444499|[qnco]|["0/5"-tx-8-"0.5"-fraction-0,"0/5"-tx-4-"0.5"-real_number-0]|TX|2921/3;1566/3|
00000000|MMI|5.30|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-23-"pain"-noun-0,"Pain NOS"-tx-4-"Pain"-noun-0]|TX|4455/4;1817/4|
00000000|MMI|5.29|Every eight hours|C0585326|[tmco]|["Q8H"-tx-4-"Q8H"-noun-0,"Q8H"-tx-2-"Q8H"-noun-0]|TX|1754/3;739/3|
00000000|MMI|5.29|Every four hours|C0585324|[tmco]|["Q4H"-tx-8-"Q4H"-noun-0,"Q4H"-tx-2-"Q4H"-noun-0]|TX|2932/3;488/3|
00000000|MMI|5.29|milliliter|C0439242|[qnco]|["MILLILITER"-tx-4-"milliliters"-noun-0]|TX|[1624/11],[1690/11]|
00000000|MMI|5.27|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-23-"Sat"-noun-0,"SAT"-tx-8-"sat"-noun-0]|TX|4431/3;3204/3|
00000000|MMI|5.27|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-23-"Sat"-noun-0,"SAT"-tx-8-"sat"-noun-0]|TX|4431/3;3204/3|
00000000|MMI|5.27|NEB gene|C1417656|[gngm]|["NEB"-tx-8-"NEB"-noun-0,"NEB"-tx-2-"NEB"-noun-0]|TX|2556/3;580/3|
00000000|MMI|5.27|Nebulizer solution|C1300458|[bodm]|["Neb"-tx-8-"NEB"-noun-0,"Neb"-tx-2-"NEB"-noun-0]|TX|2556/3;580/3|
00000000|MMI|5.02|Woman|C0043210|[popg]|["WOMAN"-tx-10-"woman"-noun-0]|TX|3797/5|M01.975
00000000|MMI|3.96|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-27-"patient"-noun-0]|TX|4644/7|
00000000|MMI|3.96|Acetaminophen [EPC]|C2917659|[phsu]|["Acetaminophen"-tx-2-"ACETAMINOPHEN"-noun-0]|TX|462/13|
00000000|MMI|3.96|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-10-"OPERATIONS"-noun-0]|TX|3676/10|
00000000|MMI|3.96|Affecting|C0392760|[ftcn]|["Affecting"-tx-10-"affecting"-verb-0]|TX|3509/9|
00000000|MMI|3.96|Allegra|C1110594|[orch,phsu]|["Allegra"-tx-7-"ALLEGRA"-noun-0]|TX|2387/7|
00000000|MMI|3.96|Antimicrobial susceptibility|C0427965|[fndg]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-19-"ASA"-noun-0]|TX|4265/3|
00000000|MMI|3.96|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-19-"CV"-noun-0]|TX|4238/2|
00000000|MMI|3.96|Complication|C0009566|[patf]|["Complications"-tx-10-"Complications"-noun-0]|TX|3493/13|
00000000|MMI|3.96|Cyclobenzaprine hydrochloride|C0125988|[orch,phsu]|["cyclobenzaprine hcl"-tx-4-"CYCLOBENZAPRINE HCL"-noun-0]|TX|924/19|
00000000|MMI|3.96|Diagnostic Sensitivity|C1511883|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-20-"GI"-noun-0]|TX|4293/2|
00000000|MMI|3.96|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|127/14|
00000000|MMI|3.96|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|127/14|
00000000|MMI|3.96|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|401/11|
00000000|MMI|3.96|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|401/11|
00000000|MMI|3.96|Echo (insect)|C1655045|[euka]|["Echo"-tx-19-"ECHO"-noun-0]|TX|4271/4|
00000000|MMI|3.96|Extended Release Dosage Form|C1707968|[bodm]|["Extended Release"-tx-6-"EXTENDED RELEASE"-adj-0]|TX|2239/16|
00000000|MMI|3.96|Fexofenadine hydrochloride|C0771752|[orch,phsu]|["Fexofenadine HCl"-tx-7-"FEXOFENADINE HCL"-noun-0]|TX|2397/16|
00000000|MMI|3.96|First (number)|C0205435|[qnco]|["First"-tx-30-"first"-adj-0]|TX|4864/5|
00000000|MMI|3.96|Firstly|C1279901|[qlco]|["First"-tx-30-"first"-adj-0]|TX|4864/5|
00000000|MMI|3.96|Fluticasone propionate|C0117996|[orch,phsu]|["FLUTICASONE PROPIONATE"-tx-8-"FLUTICASONE PROPIONATE"-noun-0]|TX|2726/22|
00000000|MMI|3.96|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-20-"GI"-noun-0]|TX|4293/2|
00000000|MMI|3.96|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-20-"GI"-noun-0]|TX|4293/2|
00000000|MMI|3.96|General medical service|C3812897|[hlca]|["General"-tx-12-"general"-adj-0]|TX|3951/7|
00000000|MMI|3.96|Generalized|C0205246|[spco]|["General"-tx-12-"general"-adj-0]|TX|3951/7|
00000000|MMI|3.96|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-10-"OPERATIONS"-noun-0]|TX|3676/10|
00000000|MMI|3.96|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-10-"hypertension"-noun-0]|TX|3549/12|
00000000|MMI|3.96|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-27-"patient"-noun-0]|TX|4644/7|
00000000|MMI|3.96|Identifier|C0600091|[inpr]|["ID"-tx-17-"ID"-noun-0]|TX|4187/2|
00000000|MMI|3.96|Immune diffusion|C1441613|[lbpr]|["ID"-tx-17-"ID"-noun-0]|TX|4187/2|
00000000|MMI|3.96|Increased Sensitivy|C2346484|[phpr]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-10-"PROCEDURES"-noun-0]|TX|3691/10|
00000000|MMI|3.96|Involvement with|C1314939|[ftcn]|["Affecting"-tx-10-"affecting"-verb-0]|TX|3509/9|
00000000|MMI|3.96|MANEA gene|C1427293|[gngm]|["ENDO"-tx-21-"Endo"-adj-0]|TX|4309/4|
00000000|MMI|3.96|Miacalcin|C0721702|[aapp,phsu]|["Miacalcin"-tx-2-"MIACALCIN"-noun-0]|TX|623/9|
00000000|MMI|3.96|Most|C0205393|[qnco]|["Most"-tx-22-"most"-adv-0]|TX|4361/4|
00000000|MMI|3.96|Never (frequency)|C2003901|[tmco]|["NEVER"-tx-10-"never"-adv-0]|TX|3849/5|
00000000|MMI|3.96|Observed|C1441672|[ftcn]|["Observe"-tx-4-"observe"-verb-0]|TX|895/7|
00000000|MMI|3.96|Offspring|C0680063|[famg]|["Children"-tx-2-"CHILDREN"-noun-0]|TX|528/8|
00000000|MMI|3.96|Peripherally inserted central catheter (physical object)|C0179740|[medd]|["picc"-tx-18-"Picc"-noun-0]|TX|4214/4|
00000000|MMI|3.96|Personality Sensitivity|C0312418|[menp]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-22-"likely"-adv-0]|TX|4366/6|
00000000|MMI|3.96|Probably|C0750492|[idcn]|["Likely"-tx-22-"likely"-adv-0]|TX|4366/6|
00000000|MMI|3.96|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-10-"PROCEDURES"-noun-0]|TX|3691/10|
00000000|MMI|3.96|Pulmonary (qualifier value)|C2709248|[qlco]|["Pulmonary"-tx-13-"pulmonary"-adj-0]|TX|4086/9|
00000000|MMI|3.96|Pulmonary:-:Point in time:^Patient:-|C2707265|[clna]|["Pulmonary"-tx-13-"pulmonary"-adj-0]|TX|4086/9|
00000000|MMI|3.96|S prime|C2603362|[clna]|["S'"-tx-8-"("-noun-0]|TX|3265/1|
00000000|MMI|3.96|Safety Reporting Documentation|C3891294|[inpr]|["General"-tx-12-"general"-adj-0]|TX|3951/7|
00000000|MMI|3.96|Shellfish - dietary|C0036950|[food]|["Shellfish"-tx-10-"Shellfish"-noun-0]|TX|3325/9|
00000000|MMI|3.96|Signal Sensitivity|C2349185|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Statistical sensitivity|C0036667|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-27-"patient"-noun-0]|TX|4644/7|
00000000|MMI|3.96|Sustained Release Dosage Form|C1710261|[bodm]|["Sustained Release"-tx-4-"SUSTAINED RELEASE"-adj-0]|TX|1779/17|
00000000|MMI|3.96|TNFSF13B wt Allele|C2986676|[gngm]|["THANK"-tx-4-"thank"-verb-0]|TX|1222/5|
00000000|MMI|3.96|Usage|C0457083|[ftcn]|["Use"-tx-4-"use"-verb-0]|TX|1149/3|
00000000|MMI|3.96|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-4-"use"-verb-0]|TX|1149/3|
00000000|MMI|3.96|Worse|C1457868|[fndg]|["worsen"-tx-27-"worsens"-verb-0]|TX|4652/7|
00000000|MMI|3.96|Worsening pattern|C0332271|[qlco]|["worsens"-tx-27-"worsens"-verb-0]|TX|4652/7|
00000000|MMI|3.96|per second|C0565930|[qnco]|["/s"-tx-8-"("-noun-0]|TX|3265/1|
00000000|MMI|3.96|stimulus sensitivity|C1522640|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|837/11|
00000000|MMI|3.96|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-10-"TREATMENTS/PROCEDURES"-noun-0]|TX|3714/21|
00000000|MMI|3.04|Place|C0442504|[spco]|["Place"-tx-18-"placed"-verb-0]|TX|4219/6|
00000000|MMI|3.04|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-18-"placed"-verb-0]|TX|4219/6|
00000000|MMI|3.04|Show|C1547282|[anim]|["Show"-tx-19-"showed"-verb-0]|TX|4276/6|
00000000|MMI|3.04|put - instruction imperative|C1882509|[acty]|["Place"-tx-18-"placed"-verb-0]|TX|4219/6|
00000000|MMI|2.89|On treatment for hypertension|C0578998|[hlca]|["treatment hypertension"-tx-10-"Treatment hypertension"-noun-0]|TX|3519/9,3534/12|
00000000|MMI|2.87|Back Pain Adverse Event|C1963071|[fndg]|["Back pain"-tx-22-"back pain"-noun-0]|TX|4349/9|
00000000|MMI|2.87|Bactrim DS|C1154231|[orch,phsu]|["Bactrim DS"-tx-6-"BACTRIM DS"-noun-0]|TX|2149/10|
00000000|MMI|2.87|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|429/21|
00000000|MMI|2.87|Phase II/III Trial|C1519042|[resa]|["2-3"-tx-1-"2/3"-fraction-0]|TX|143/3|
00000000|MMI|2.86|Domestic activities|C0441660|[dora]|["house activity"-tx-8-"House ACTIVITY"-noun-0]|TX|3183/5,3213/8|
00000000|MMI|2.84|Less Than|C0439092|[qnco]|["Less Than"-tx-4-"less than"-adv-0]|TX|1241/9|
00000000|MMI|2.84|Sensitive|C0332324|[ftcn]|["Sensitive to"-tx-11-"Sensitive to"-adj-0]|TX|3907/12|
00000000|MMI|2.83|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-10-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3362/9,3382/9|
00000000|MMI|2.83|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-10-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3362/9,3382/9|
00000000|MMI|2.81|3/9|C0442760|[fndg]|["3/9"-tx-8-"3/9"-fraction-0]|TX|3103/3|
00000000|MMI|2.81|Admission activity|C0809949|[hlca]|["Admission"-tx-10-"Admission"-noun-0]|TX|3429/9|
00000000|MMI|2.81|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|85/14|
00000000|MMI|2.81|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-12-"Chest"-noun-0]|TX|3990/5|
00000000|MMI|2.81|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|361/9|
00000000|MMI|2.81|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|361/9|
00000000|MMI|2.81|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|85/14|
00000000|MMI|2.81|Entire abdomen|C1281594|[bpoc]|["Abdomen"-tx-12-"Abdomen"-noun-0]|TX|4045/7|
00000000|MMI|2.81|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-4-"Instructions"-noun-0]|TX|1131/12|
00000000|MMI|2.81|S1|C3715215|[fndg]|["S1"-tx-12-"S1"-noun-0]|TX|4037/2|
00000000|MMI|2.81|STX8 gene|C1420505|[gngm]|["CARB"-tx-8-"CARB"-noun-0]|TX|2793/4|
00000000|MMI|2.81|Singulair|C0595724|[orch,phsu]|["Singulair"-tx-8-"SINGULAIR"-noun-0]|TX|2664/9|
00000000|MMI|2.81|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-12-"S1"-noun-0]|TX|4037/2|
00000000|MMI|2.81|dalton|C0678223|[qnco]|["Dalton"-tx-1-"DALTON"-noun-0]|TX|387/6|
00000000|MMI|2.81|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-10-"DISCHARGE DIAGNOSIS"-noun-0]|TX|3372/19|
00000000|MMI|2.80|Recurrent pneumonia|C0694550|[dsyn]|["Pneumonia, recurrent"-tx-10-"recurrent pneumonia"-noun-0]|TX|3874/9,3896/9|
00000000|MMI|2.79|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|112/13|
00000000|MMI|2.78|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|283/10|
00000000|MMI|2.78|Entered|C1521975|[qlco]|["Entered"-tx-31-"ENTERED"-verb-0]|TX|4949/7|
00000000|MMI|2.78|Greater Than|C0439093|[qnco]|["Greater Than"-tx-4-"greater than"-adj-0]|TX|1528/12|
00000000|MMI|2.78|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-4-"Reason"-verb-0]|TX|869/6|
00000000|MMI|2.78|Additional comments|C1830770|[fndg]|["Additional comments"-tx-26-"ADDITIONAL COMMENTS"-noun-0]|TX|4549/19|
00000000|MMI|2.78|FST wt Allele|C3814419|[gngm]|["FS"-tx-21-"fs"-noun-0]|TX|4315/2|
00000000|MMI|2.78|French Southern Territories|C1517317|[geoa]|["FS"-tx-21-"fs"-noun-0]|TX|4315/2|
00000000|MMI|2.78|HEENT|C1512338|[blor]|["HEENT"-tx-12-"HEENT"-noun-0]|TX|3972/5|
00000000|MMI|2.77|Prednisone 20 MG|C0989247|[clnd]|["Prednisone 20 MG"-tx-8-"PREDNISONE 20 mg"-noun-0]|TX|3154/10,3168/5|
00000000|MMI|2.76|14D|C4071839|[tmco]|["14D"-tx-28-"14d"-noun-0]|TX|4722/3|
00000000|MMI|2.75|Caltrate|C0719118|[inch,phsu]|["Caltrate"-tx-8-"CALTRATE"-noun-0]|TX|2770/8|
00000000|MMI|2.75|DuoNeb|C0939692|[orch,phsu]|["DuoNeb"-tx-8-"DUONEB"-noun-0]|TX|2872/6|
00000000|MMI|2.75|Experimental Result|C2825142|[fndg]|["Result"-tx-4-"results"-noun-0]|TX|1165/7|
00000000|MMI|2.75|Result|C1274040|[ftcn]|["Result"-tx-4-"results"-noun-0]|TX|1165/7|
00000000|MMI|2.75|What subject filter - Result|C1546471|[idcn]|["Result"-tx-4-"results"-noun-0]|TX|1165/7|
00000000|MMI|2.75|day|C0439228|[tmco]|["DAY"-tx-8-"day"-noun-0]|TX|3092/3|
00000000|MMI|2.75|heparin, porcine|C0770546|[bacs,orch,phsu]|["HEPARIN"-tx-4-"HEPARIN"-noun-0]|TX|1044/7|
00000000|MMI|2.75|per day|C0439505|[tmco]|["/day"-tx-8-"day"-noun-0]|TX|3092/3|
00000000|MMI|2.74|50%|C3842586|[fndg]|["50%"-tx-8-"50"-fraction-0]|TX|2721/2|
00000000|MMI|2.74|<50|C3843766|[fndg]|["<50"-tx-8-"50"-fraction-0]|TX|2721/2|
00000000|MMI|2.74|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|228/7|
00000000|MMI|2.74|Maalox|C0065461|[inch,phsu]|["Maalox"-tx-4-"MAALOX"-noun-0]|TX|1594/6|
00000000|MMI|2.74|Multiple of the median|C1442163|[qnco]|["MoM"-tx-4-"MOM"-noun-0]|TX|1659/3|
00000000|MMI|2.74|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|228/7|
00000000|MMI|2.74|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|228/7|
00000000|MMI|2.74|mycolate outer membrane|C3811401|[celc]|["MOM"-tx-4-"MOM"-noun-0]|TX|1659/3|
00000000|MMI|2.74|Done (qualifier value)|C1272695|[qlco]|["Done"-tx-8-"done"-aux-0]|TX|3126/4|
00000000|MMI|2.74|End|C0444930|[spco]|["End"-tx-33-"END"-noun-0]|TX|5015/3|
00000000|MMI|2.74|Finger-prick sampling (procedure)|C0457575|[diap]|["Finger Stick"-tx-4-"fingerstick"-noun-0]|TX|1203/11|
00000000|MMI|2.74|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-24-"pt"-noun-0]|TX|4504/2|
00000000|MMI|2.74|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-24-"pt"-noun-0]|TX|4504/2|
00000000|MMI|2.74|Responsible to|C1273518|[fndg]|["Responsible"-tx-10-"Responsible"-adj-0]|TX|3393/11|
00000000|MMI|2.74|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-33-"END"-noun-0]|TX|5015/3|
00000000|MMI|2.73|Negation|C1518422|[ftcn]|["Not"-tx-10-"NOT"-adv-0]|TX|3738/3|
00000000|MMI|2.73|R prime|C2603358|[clna]|["R'"-tx-10-"R"-noun-0]|TX|3747/1|
00000000|MMI|2.73|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-27-"return"-noun-0]|TX|4669/6|
00000000|MMI|2.73|Right|C0205090|[spco]|["R-"-tx-10-"R"-noun-0]|TX|3747/1|
00000000|MMI|2.73|Switch Device Component|C1707719|[mnob]|["Switch"-tx-26-"switch"-noun-0]|TX|4615/6|
00000000|MMI|2.72|Additional|C1524062|[ftcn]|["Added"-tx-2-"added"-verb-0]|TX|770/5|
00000000|MMI|2.72|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-2-"Shortness of Breath"-noun-0]|TX|592/19|
00000000|MMI|2.72|Concept Attribute|C0449234|[idcn]|["Attribute"-tx-22-"attributed"-verb-0]|TX|4373/10|
00000000|MMI|2.72|Object Attribute|C1882133|[qlco]|["Attribute"-tx-22-"attributed"-verb-0]|TX|4373/10|
00000000|MMI|2.72|Protection Element Attribute|C1704772|[cnce]|["Attribute"-tx-22-"attributed"-verb-0]|TX|4373/10|
00000000|MMI|2.72|asthma with copd|C0865800|[dsyn]|["asthma copd"-tx-10-"asthma/COPD"-noun-0]|TX|3813/11|
00000000|MMI|2.71|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-10-"RESUME"-noun-0]|TX|3763/6|
00000000|MMI|2.71|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-10-"RESUME"-noun-0]|TX|3763/6|
00000000|MMI|2.71|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|332/4|
00000000|MMI|2.71|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-10-"RESUME"-noun-0]|TX|3763/6|
00000000|MMI|2.70|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-8-"FOLLOW UP"-adj-0]|TX|3244/9|
00000000|MMI|2.70|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|319/3|
00000000|MMI|2.70|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-8-"FOLLOW UP"-adj-0]|TX|3244/9|
00000000|MMI|2.70|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-8-"FOLLOW UP"-adj-0]|TX|3244/9|
00000000|MMI|2.70|follow-up|C1522577|[hlca]|["Follow Up"-tx-8-"FOLLOW UP"-adj-0]|TX|3244/9|
00000000|MMI|2.68|6/3|C1630409|[fndg]|["20/10"-tx-8-"20 10"-integer-0]|TX|3078/2,3089/2|
00000000|MMI|2.68|+5|C0728893|[qnco]|["+5"-tx-4-"5"-integer-0]|TX|1001/1|
00000000|MMI|2.68|>5|C0439084|[qnco]|[">5"-tx-4-"5"-integer-0]|TX|1001/1|
00000000|MMI|2.68|CALCIUM SUPPLEMENTS|C3540037|[phsu,vita]|["CALCIUM"-tx-8-"CALCIUM"-noun-0]|TX|2785/7|
00000000|MMI|2.68|Calcium Drug Class|C3714611|[phsu]|["CALCIUM"-tx-8-"CALCIUM"-noun-0]|TX|2785/7|
00000000|MMI|2.68|Calcium [EPC]|C2936886|[phsu]|["Calcium"-tx-8-"CALCIUM"-noun-0]|TX|2785/7|
00000000|MMI|2.68|Causing|C0678227|[ftcn]|["Causing"-tx-10-"Causing"-adj-0]|TX|3421/7|
00000000|MMI|2.68|Cushingoid facies|C0332601|[sosy]|["CUSHINGOID"-tx-12-"Cushingoid"-adj-0]|TX|3979/10|
00000000|MMI|2.68|PSMD2 gene|C1419032|[gngm]|["S2"-tx-12-"S2"-noun-0]|TX|4042/2|
00000000|MMI|2.68|Page (document)|C1704732|[inpr]|["Page"-tx-29-"page"-noun-0]|TX|4798/4|
00000000|MMI|2.68|Possible|C0332149|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|815/8|
00000000|MMI|2.68|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|815/8|
00000000|MMI|2.68|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|815/8|
00000000|MMI|2.68|RPS2 gene|C1419718|[gngm]|["S2"-tx-12-"S2"-noun-0]|TX|4042/2|
00000000|MMI|2.68|S2|C3812876|[fndg]|["S2"-tx-12-"S2"-noun-0]|TX|4042/2|
00000000|MMI|2.68|S2 innervation|C1179705|[blor]|["S2"-tx-12-"S2"-noun-0]|TX|4042/2|
00000000|MMI|2.68|Testicular Cancer Serum Markers Test Result S2|C3812875|[lbtr]|["S2"-tx-12-"S2"-noun-0]|TX|4042/2|
00000000|MMI|2.68|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|357/3|
00000000|MMI|2.68|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|357/3|
00000000|MMI|2.68|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-31-"dictated"-adj-0]|TX|4932/8|
00000000|MMI|2.68|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-31-"dictated"-adj-0]|TX|4932/8|
00000000|MMI|2.67|Lisinopril 20 MG|C0987219|[clnd]|["Lisinopril 20 MG"-tx-6-"LISINOPRIL 20 MG"-noun-0]|TX|2039/10,2069/2,2075/2|
00000000|MMI|2.66|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-6-"CR"-noun-0]|TX|1970/2|
00000000|MMI|2.66|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-6-"CR"-noun-0]|TX|1970/2|
00000000|MMI|2.66|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-2-"Rehabilitation"-noun-0]|TX|414/14|
00000000|MMI|2.66|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-12-"soft"-adj-0]|TX|4054/4|
00000000|MMI|2.66|Scattered|C0439742|[spco]|["Scattered"-tx-12-"scattered"-adj-0]|TX|4008/9|
00000000|MMI|2.66|Soft|C0205358|[qlco]|["Soft"-tx-12-"soft"-adj-0]|TX|4054/4|
00000000|MMI|2.66|persistent|C0205322|[tmco]|["Persistent"-tx-22-"Persistent"-adj-0]|TX|4338/10|
00000000|MMI|2.65|3/5|C0442758|[qnco]|["3 5"-tx-8-"3 5"-fraction-0]|TX|2919/1,2923/1|
00000000|MMI|2.65|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-4-"call"-noun-0]|TX|1503/4|
00000000|MMI|2.65|Decision|C0679006|[menp]|["Call"-tx-4-"call"-noun-0]|TX|1503/4|
00000000|MMI|2.65|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|79/3|
00000000|MMI|2.65|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-4-"HO"-noun-0]|TX|1508/2|
00000000|MMI|2.65|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-4-"HO"-noun-0]|TX|1508/2|
00000000|MMI|2.65|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-30-"Stable"-adj-0]|TX|4891/6|
00000000|MMI|2.65|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-4-"call"-noun-0]|TX|1503/4|
00000000|MMI|2.65|Primary|C0205225|[qlco]|["Principal"-tx-10-"PRINCIPAL"-adj-0]|TX|3362/9|
00000000|MMI|2.65|Stable status|C0205360|[qlco]|["STABLE"-tx-30-"Stable"-adj-0]|TX|4891/6|
00000000|MMI|2.65|Teaching principal|C0401925|[prog]|["Principal"-tx-10-"PRINCIPAL"-adj-0]|TX|3362/9|
00000000|MMI|2.64|/40|C0439509|[tmco]|["/40"-tx-8-"40"-integer-0]|TX|2860/2|
00000000|MMI|2.64|40%|C3842587|[qnco]|["40%"-tx-8-"40"-integer-0]|TX|2860/2|
00000000|MMI|2.64|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-10-"now"-adv-0]|TX|3867/3|
00000000|MMI|2.64|20%|C3842589|[fndg]|["20%"-tx-8-"20"-integer-0]|TX|3078/2|
00000000|MMI|2.64|Alert|C3665546|[ftcn]|["Alert"-tx-2-"Alert"-noun-0]|TX|743/5|
00000000|MMI|2.64|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-2-"Alert"-noun-0]|TX|743/5|
00000000|MMI|2.64|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-2-"Alert"-noun-0]|TX|743/5|
00000000|MMI|2.64|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-8-"chol"-noun-0]|TX|3195/4|
00000000|MMI|2.64|Every twelve hours|C0585327|[tmco]|["Q12H"-tx-4-"Q12H"-noun-0]|TX|1808/4|
00000000|MMI|2.64|80%|C3842583|[fndg]|["80%"-tx-4-"80"-integer-0]|TX|1848/2|
00000000|MMI|2.64|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-4-"QHS"-noun-0]|TX|1857/3|
00000000|MMI|2.64|8 Hours|C1292429|[tmco]|["8H"-tx-4-"8H"-noun-0]|TX|1579/2|
00000000|MMI|2.64|Every six hours|C0585325|[tmco]|["Q6H"-tx-4-"Q6H"-noun-0]|TX|1639/3|
00000000|MMI|2.64|Pharmaceutical Strength|C1705922|[qnco]|["Strength"-tx-4-"STRENGTH"-noun-0]|TX|1612/8|
00000000|MMI|2.64|Physical Strength|C0237897|[qnco]|["Strength"-tx-4-"STRENGTH"-noun-0]|TX|1612/8|
00000000|MMI|2.64|QSOX1 gene|C1419185|[gngm]|["Q6"-tx-4-"Q6"-noun-0]|TX|1576/2|
00000000|MMI|2.64|STRENGTH (attribute)|C0808080|[idcn]|["Strength"-tx-4-"STRENGTH"-noun-0]|TX|1612/8|
00000000|MMI|2.64|metric ton|C0439216|[qnco]|["TON"-tx-1-"Ton"-noun-0]|TX|224/3|
00000000|MMI|2.64|Hospital course|C0489547|[fndg]|["Hospital course"-tx-10-"HOSPITAL COURSE"-noun-1]|TX|3773/15|
00000000|MMI|2.64|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-10-"HOSPITAL COURSE"-noun-0]|TX|3773/15|
00000000|MMI|2.64|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-4-"pm"-adj-0]|TX|1218/2|
00000000|MMI|2.64|Regular|C0205272|[qlco]|["Regular"-tx-4-"REGULAR"-adj-0]|TX|1077/7|
00000000|MMI|2.64|Room of building - Study|C0557651|[mnob]|["Study"-tx-10-"Study"-noun-0]|TX|3411/5|
00000000|MMI|2.64|Study|C2603343|[resa]|["Study"-tx-10-"Study"-noun-0]|TX|3411/5|
00000000|MMI|2.63|Constipation Adverse Event|C1963087|[fndg]|["Constipation"-tx-4-"Constipation"-noun-0]|TX|1712/12|
00000000|MMI|2.63|Registered Nurse - Pain Management|C1554586|[prog]|["Pain Management"-tx-30-"Pain management"-noun-0]|TX|4833/15|
00000000|MMI|2.63|PUL anatomical site notation for tumour staging|C0449197|[blor]|["PUL"-tx-1-"PUL"-noun-0]|TX|237/3|
00000000|MMI|2.62|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-13-"gt"-noun-0]|TX|4112/2|
00000000|MMI|2.62|Short-acting thyroid stimulator|C0312448|[aapp,horm,phsu]|["SATS"-tx-13-"sats"-noun-0]|TX|4106/4|
00000000|MMI|2.62|Weekly|C0332174|[tmco]|["/week"-tx-26-"week"-noun-0]|TX|4606/4|
00000000|MMI|2.62|week|C0439230|[tmco]|["WEEK"-tx-26-"week"-noun-0]|TX|4606/4|
00000000|MMI|2.62|Protuberance|C2339173|[blor]|["Protuberance"-tx-12-"protuberant"-adj-0]|TX|4059/11|
00000000|MMI|2.62|Severe asthma|C0581126|[fndg]|["Severe asthma"-tx-10-"severe asthma"-noun-0]|TX|3806/13|
00000000|MMI|2.62|Basal Diet|C2983588|[food]|["DIET"-tx-8-"DIET"-noun-0]|TX|3177/4|
00000000|MMI|2.62|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-10-"BRIEF"-adj-0]|TX|3757/5|
00000000|MMI|2.62|Brief|C1879313|[tmco]|["Brief"-tx-10-"BRIEF"-adj-0]|TX|3757/5|
00000000|MMI|2.62|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|3177/4|
00000000|MMI|2.62|Shortened|C1282927|[qlco]|["brief"-tx-10-"BRIEF"-adj-0]|TX|3757/5|
00000000|MMI|2.62|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-8-"DIET"-noun-0]|TX|3177/4|
00000000|MMI|2.62|Four times daily|C0585291|[tmco]|["QID"-tx-8-"QID"-adv-0]|TX|2615/3|
00000000|MMI|2.62|Hospital Communication Systems, Paging|C0182161|[inpr]|["pager"-tx-30-"pager"-noun-0]|TX|4820/5|
00000000|MMI|2.62|No Application Type|C1546968|[idcn]|["NA"-tx-2-"NA"-noun-0]|TX|663/2|
00000000|MMI|2.62|Pagers|C1550704|[mnob]|["Pager"-tx-30-"pager"-noun-0]|TX|4820/5|
00000000|MMI|2.62|Sodium Cation|C0597484|[elii]|["Na+"-tx-2-"NA"-noun-0]|TX|663/2|
00000000|MMI|2.62|Spray (action)|C2003858|[ftcn]|["Spray"-tx-2-"SPRAY"-noun-0]|TX|657/5|
00000000|MMI|2.62|Spray Dosing Unit|C1704413|[qnco]|["{Spray}"-tx-2-"SPRAY"-noun-0]|TX|657/5|
00000000|MMI|2.62|Three times daily|C0556984|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|955/3|
00000000|MMI|2.62|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|955/3|
00000000|MMI|2.61|mg/mg|C1319635|[qnco]|["mg/mg"-tx-2-"MG MG"-noun-0]|TX|544/2,577/2|
00000000|MMI|2.61|Entire shoulder region|C1283792|[blor]|["Shoulder"-tx-23-"shoulder"-noun-0]|TX|4422/8|
00000000|MMI|2.61|MCM8 gene|C1424025|[gngm]|["REC"-tx-23-"rec"-adj-0]|TX|4397/3|
00000000|MMI|2.61|Borg Category-Ratio 10 Perceived Exertion Score 5|C4050466|[inpr]|["Severe"-tx-10-"severe"-adj-0]|TX|3806/6|
00000000|MMI|2.61|Home environment|C0442519|[cnce]|["HOME"-tx-10-"home"-noun-0]|TX|3828/4|
00000000|MMI|2.61|Severe (severity modifier)|